Jenny Shum is counsel in Foley Hoag's Intellectual Property Litigation practice, resident in the firm's New York office. She focuses on pharmaceutical, biotechnology, medical device, biometrics and data privacy, and high technology matters. Jenny represents multinational pharmaceutical and technology clients in high-stakes litigations and international arbitrations involving patent infringement, Hatch-Waxman/ANDA, licensing, and contract issues. Jenny has experience with a variety of biotechnologies, including antibodies, antivirals, and antibiotics. In addition to patent validity and infringement matters, she has experience in domestic and international patent prosecution and patent portfolio management. Jenny also provides counsel on strategic business and intellectual property issues, including freedom-to-operate and strategic analyses, due diligence evaluations, trade secrets, trademarks, and intellectual property concerns that arise in corporate and finance transactions.More »
Industries:Life Sciences Healthcare Technology
- Boston College Law School, J.D.
- Albany Medical College, Ph.D. in Biological Sciences (Biochemistry and Molecular Biology)
- Albany Medical College, M.S., Biological Sciences (Biochemistry and Molecular Biology)
- State University of New York at Albany, B.S., Biochemistry and Molecular Biology and East Asian Studies